Adiponectin exerts its negative effect on bone metabolism via OPG/RANKL pathway: an in vivo study

Endocrine

Volumn 47, Issue 3, 2014, Pages 845-853

  Wang, Qing ping ^a,b   Li, Xian ping ^a   Wang, Min ^a   Zhao, Li ling ^a   Li, Hui ^a   Xie, Hui ^a   Lu, Zhi yong ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Bone metabolism; RANKL, OPG

Indexed keywords

ADIPONECTIN; CARBOXY TERMINAL TELOPEPTIDE; CD14 ANTIGEN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE STRUCTURE; BONE TURNOVER; COCULTURE; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OPG GENE; OSTEOBLAST; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANKL GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRABECULAR BONE; ANIMAL; CELL CULTURE; CYTOLOGY; FEMUR; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; BONE DENSITY; CELLS, CULTURED; COLLAGEN TYPE I; FEMUR; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOPROTEGERIN; PEPTIDES; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 84911956119     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0216-z     Document Type: Article

References (40)

1. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, H.F. Lodish, A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270(45), 26746–26749 (1995)
2. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, K. Matsubara, cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221(2), 286–289 (1996)
3. Y. Nakano, T. Tobe, N.H. Choi-Miura, T. Mazda, M. Tomita, Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120(4), 803–812 (1996)
4. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941), 762–769 (2003)
5. T.P. Combs, A.H. Berg, S. Obici, P.E. Scherer, L. Rossetti, Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108(12), 1875–1881 (2001)
6. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, H.F. Lodish, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98(4), 2005–2010 (2001)
7. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, T. Kadowaki, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8(11), 1288–1295 (2002)
8. K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.F. Palin, Adiponectin action from head to toe. Endocrine 37(1), 11–32 (2010)
9. H.S. Berner, S.P. Lyngstadaas, A. Spahr, M. Monjo, L. Thommesen, C.A. Drevon, U. Syversen, J.E. Reseland, Adiponectin and its receptors are expressed in bone-forming cells. Bone 35(4), 842–849 (2004)
10. K.N. Ealey, J. Kaludjerovic, M.C. Archer, W.E. Ward, Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp. Biol. Med. (Maywood) 233(12), 1546–1553 (2008)
11. G.A. Williams, Y. Wang, K.E. Callon, M. Watson, J.M. Lin, J.B. Lam, J.L. Costa, A. Orpe, N. Broom, D. Naot, I.R. Reid, J. Cornish, In vitro and in vivo effects of adiponectin on bone. Endocrinology 150(8), 3603–3610 (2009)
12. J. Jurimae, T. Jurimae, Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am. J. Physiol. Endocrinol. Metab. 293(1), E42–E47 (2007)
13. X.D. Peng, H. Xie, Q. Zhao, X.P. Wu, Z.Q. Sun, E.Y. Liao, Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin. Chim. Acta 387(1–2), 31–35 (2008)
14. B. Bozic, G. Loncar, N. Prodanovic, Z. Radojicic, V. Cvorovic, S. Dimkovic, V. Popovic-Brkic, Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure. J. Card Fail. 16(4), 301–307 (2010)
15. L. Basurto, R. Galvan, N. Cordova, R. Saucedo, C. Vargas, S. Campos, E. Halley, F. Avelar, A. Zarate, Adiponectin is associated with low bone mineral density in elderly men. Eur. J. Endocrinol. 160(2), 289–293 (2009)
16. X.H. Luo, L.J. Guo, L.Q. Yuan, H. Xie, H.D. Zhou, X.P. Wu, E.Y. Liao, Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res. 309(1), 99–109 (2005)
17. H.W. Lee, S.Y. Kim, A.Y. Kim, E.J. Lee, J.Y. Choi, J.B. Kim, Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27(9), 2254–2262 (2009)
18. N. Yamaguchi, T. Kukita, Y.J. Li, J.G. Martinez Argueta, T. Saito, S. Hanazawa, Y. Yamashita, Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol. Med. Microbiol. 49(1), 28–34 (2007)
19. K. Oshima, A. Nampei, M. Matsuda, M. Iwaki, A. Fukuhara, J. Hashimoto, H. Yoshikawa, I. Shimomura, Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331(2), 520–526 (2005)
20. X.H. Luo, L.J. Guo, H. Xie, L.Q. Yuan, X.P. Wu, H.D. Zhou, E.Y. Liao, Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 21(10), 1648–1656 (2006)
21. S. Khosla, Minireview: the OPG/RANKL/RANK system. Endocrinology 142(12), 5050–5055 (2001)
22. Q.P. Wang, L. Yang, X.P. Li, H. Xie, E.Y. Liao, M. Wang, X.H. Luo, Effects of 17beta-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand. Bone 51(3), 515–523 (2012)
23. A. Geldyyev, N. Koleganova, G. Piecha, H. Sueltmann, K. Finis, M. Ruschaupt, A. Poustka, M.L. Gross, I. Berger, High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 255(2), 275–283 (2007)
24. G. Musso, Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine 42(2), 237–239 (2012)
25. H. Zhang, X. Chai, S. Li, Z. Zhang, L. Yuan, H. Xie, H. Zhou, X. Wu, Z. Sheng, E. Liao, Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine 43(3), 643–650 (2013)
26. H. Li, H. Xie, W. Liu, R. Hu, B. Huang, Y.F. Tan, K. Xu, Z.F. Sheng, H.D. Zhou, X.P. Wu, X.H. Luo, A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest. 119(12), 3666–3677 (2009)
27. P. Cheng, C. Chen, H.B. He, R. Hu, H.D. Zhou, H. Xie, W. Zhu, R.C. Dai, X.P. Wu, E.Y. Liao, X.H. Luo, miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J. Bone Miner. Res. 28(5), 1180–1190 (2013)
28. K. Agbaht, A. Gurlek, J. Karakaya, M. Bayraktar, Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 35(3), 371–379 (2009)
29. L. Lenchik, T.C. Register, F.C. Hsu, K. Lohman, B.J. Nicklas, B.I. Freedman, C.D. Langefeld, J.J. Carr, D.W. Bowden, Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33(4), 646–651 (2003)
30. J.B. Richards, A.M. Valdes, K. Burling, U.C. Perks, T.D. Spector, Serum adiponectin and bone mineral density in women. J. Clin. Endocrinol. Metab. 92(4), 1517–1523 (2007)
31. E. Biver, C. Salliot, C. Combescure, L. Gossec, P. Hardouin, I. Legroux-Gerot, B. Cortet, Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(9), 2703–2713 (2011)
32. P. Szulc, P.D. Delmas, Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos. Int. 19(12), 1683–1704 (2008)
33. S.L. Teitelbaum, Bone resorption by osteoclasts. Science 289(5484), 1504–1508 (2000)
34. J.M. Blair, H. Zhou, M.J. Seibel, C.R. Dunstan, Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat. Clin. Pract. Oncol. 3(1), 41–49 (2006)
35. L.C. Hofbauer, C.A. Kuhne, V. Viereck, The OPG/RANKL/RANK system in metabolic bone diseases. J. Musculoskelet. Neuronal Interact. 4(3), 268–275 (2004)
36. A. Rogers, R. Eastell, Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J. Clin. Endocrinol. Metab. 90(11), 6323–6331 (2005)
37. E.M. Lewiecki, RANK ligand inhibition with denosumab for the management of osteoporosis. Expert. Opin. Biol. Ther. 6(10), 1041–1050 (2006)
38. G. Schett, S. Hayer, J. Zwerina, K. Redlich, J.S. Smolen, Mechanisms of disease: the link between RANKL and arthritic bone disease. Nat. Clin. Pract. Rheumatol. 1(1), 47–54 (2005)
39. S. Kudlacek, B. Schneider, W. Woloszczuk, P. Pietschmann, R. Willvonseder, Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone 32(6), 681–686 (2003)
40. Y. Shinoda, M. Yamaguchi, N. Ogata, T. Akune, N. Kubota, T. Yamauchi, Y. Terauchi, T. Kadowaki, Y. Takeuchi, S. Fukumoto, T. Ikeda, K. Hoshi, U.I. Chung, K. Nakamura, H. Kawaguchi, Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell. Biochem. 99(1), 196–208 (2006)